Reproductive Endocrinology Practice Questions

Q: Precocious puberty is most characteristic of which of the following conditions?

Albright's syndrome. **Explanation:** **Albright’s Syndrome** (specifically McCune-Albright Syndrome) is the correct answer because it is a classic cause of **GnRH-independent (peripheral) precocious puberty**. It is characterized by a clinical triad: 1. **Polyostotic fibrous dysplasia:** Multiple cystic bone lesions. 2. **Café-au-lait spots:** Large, irregular skin pigmentations (often described as having "Coast of Maine" borders). 3. **Autonomous endocrine hyperfunction:** Most commonly presenting as precocious puberty due to estrogen secretion from ovarian cysts. The underlying pathophysiology involves a somatic mutation in the **GNAS gene**, leading to constitutive activation of the G-protein signaling (adenylate cyclase), which mimics the effect of continuous hormonal stimulation (FSH/LH) on the ovaries. **Analysis of Incorrect Options:** * **Jaffe’s Syndrome:** This is a variant of fibrous dysplasia that presents with café-au-lait spots and bone lesions but **lacks** the endocrine abnormalities (precocious puberty) seen in McCune-Albright. * **Monostotic fibrous dysplasia:** This involves a single bone lesion and is not associated with systemic endocrine manifestations or skin pigmentation. * **Osteogenesis imperfecta:** A genetic disorder of Type 1 collagen characterized by brittle bones, blue sclera, and hearing loss, but it does not cause precocious puberty. **High-Yield Clinical Pearls for NEET-PG:** * **McCune-Albright Syndrome** is more common in girls. * It is a **peripheral** cause of precocious puberty; therefore, LH/FSH levels will be suppressed (low), and the patient will not respond to GnRH analogues. * The café-au-lait spots in this syndrome are typically unilateral and do not cross the midline. * **Treatment:** Aromatase inhibitors (e.g., Letrozole) or Estrogen receptor antagonists (e.g., Tamoxifen) are used to manage the precocity.

Q: A sample of cervical mucus is taken on Day 12 of the menstrual cycle. The mucus is thin, clear, and elastic. When placed under a microscope, what microscopic finding would be expected?

A fern pattern characteristic of estrogen. **Explanation:** The correct answer is **C. A fern pattern characteristic of estrogen.** **1. Why the correct answer is right:** On Day 12 of a typical 28-day menstrual cycle (the late follicular/pre-ovulatory phase), estrogen levels are at their peak. High estrogen levels act on the cervical glands to produce mucus that is thin, watery, alkaline, and rich in sodium chloride. When this mucus is dried on a glass slide, the crystallization of the salts creates a characteristic microscopic appearance known as **arborization** or a **"fern pattern."** This change increases the "Spinnbarkeit" (elasticity), facilitating sperm penetration and survival. **2. Why the incorrect options are wrong:** * **Option A:** While the mucus is clear clinically, a "clear field" under a microscope is not a diagnostic finding for cycle dating. The presence or absence of bacteria is not the defining feature of the periovulatory phase. * **Option B:** Thick mucus with background cellularity/bacteria is characteristic of the **luteal phase** (post-ovulation). Under the influence of **progesterone**, cervical mucus becomes thick, viscous, and cellular, which inhibits the fern pattern (anti-estrogenic effect). * **Option D:** Parabasal cells are a feature of vaginal cytology in low-estrogen states (e.g., menopause or prepuberty), not a finding in cervical mucus during the reproductive cycle. **3. NEET-PG High-Yield Pearls:** * **Ferning (Arborization):** Indicates high estrogen; disappears after Day 21 due to progesterone. * **Spinnbarkeit Test:** Measures the elasticity of mucus. Maximum elasticity (>10 cm) occurs just before ovulation. * **Progesterone Effect:** Causes "Beading" or a cellular pattern; it is the basis for using cervical mucus as a natural contraceptive method (Billings method). * **Palm Leaf Pattern:** Another name for the fern pattern seen in cervical mucus.

Q: Which of the following clinical features is seen in Polycystic Ovarian Disease (PCOD)?

Streak ovaries. **Explanation:** The question asks for a clinical feature **not** typically associated with Polycystic Ovarian Disease (PCOD/PCOS), as **Streak Ovaries** is the characteristic finding in **Turner Syndrome (45,XO)** and Pure Gonadal Dysgenesis, not PCOD. **1. Why "Streak Ovaries" is the Correct Answer (The Exception):** In PCOD, the ovaries are typically **enlarged** (volume >10cc) with multiple small peripheral follicles (string-of-pearls appearance). In contrast, **streak ovaries** occur due to accelerated atresia of germ cells, resulting in fibrous tissue bands devoid of follicles. This is a hallmark of hypergonadotropic hypogonadism (e.g., Turner Syndrome). **2. Analysis of Incorrect Options:** * **Hirsutism:** This is a classic feature of PCOD, resulting from **hyperandrogenism**. It is clinically graded using the Modified Ferriman-Gallwey score. * **Secondary Amenorrhea:** PCOD is the most common cause of chronic anovulation. Patients typically present with oligomenorrhea or secondary amenorrhea due to the lack of progesterone withdrawal. * **Elevated FSH/LH ratio:** This is a distractor. In PCOD, the **LH/FSH ratio is increased** (typically >2:1 or 3:1) because of increased GnRH pulse frequency. Therefore, a "decreased" FSH/LH ratio is seen, but the presence of hormonal imbalance remains a core feature. **High-Yield Clinical Pearls for NEET-PG:** * **Rotterdam Criteria (2 out of 3):** 1. Clinical/Biochemical Hyperandrogenism, 2. Oligo/Anovulation, 3. Polycystic ovaries on USG. * **Gold Standard Investigation:** Transvaginal Ultrasound (TVS). * **Metabolic Link:** Hyperinsulinemia and Insulin Resistance are central to the pathogenesis. * **Drug of Choice:** Clomiphene Citrate (traditional) or **Letrozole** (current first-line for ovulation induction).

Q: Which of the following is NOT a typical sign of hyperandrogenism seen in Polycystic Ovary Syndrome (PCOS)?

Clitoromegaly. **Explanation:** In Polycystic Ovary Syndrome (PCOS), hyperandrogenism is typically **biochemical** (elevated serum testosterone/androstenedione) or **clinical** (signs of mild-to-moderate androgen excess). **Why Clitoromegaly is the correct answer:** Clitoromegaly is a sign of **virilization**, not simple hyperandrogenism. Virilization involves extreme androgen excess that causes masculine physical changes, including clitoromegaly (clitoral index >35 $mm^2$), deepening of the voice, and increased muscle mass. If a patient presents with these signs, clinicians must rule out more serious pathologies like **Androgen-Secreting Ovarian Tumors** (e.g., Sertoli-Leydig cell tumors) or **Adrenal Tumors**, as PCOS rarely produces androgen levels high enough to cause structural changes like clitoromegaly. **Analysis of Incorrect Options:** * **A. Hirsutism:** The most common clinical sign of PCOS (seen in ~70% of cases), characterized by terminal hair growth in a male-pattern distribution (measured by the Modified Ferriman-Gallwey score). * **C. Androgenic Alopecia:** Thinning of scalp hair, typically in the vertex or crown area, is a recognized cutaneous manifestation of hyperandrogenism in PCOS. * **D. Acne:** Persistent inflammatory acne, especially in the "U-zone" (jawline), is a common dermatological marker of elevated circulating androgens. **NEET-PG High-Yield Pearls:** * **Rotterdam Criteria (2003):** Diagnosis requires 2 out of 3: (1) Oligo/Anovulation, (2) Hyperandrogenism (Clinical/Biochemical), (3) Polycystic ovaries on USG. * **Virilization vs. Hyperandrogenism:** PCOS = Hyperandrogenism; Ovarian/Adrenal Tumors = Virilization. * **Gold Standard for Hirsutism:** Modified Ferriman-Gallwey (mFG) score; a score $\geq$ 8 is significant in the Indian population.

Q: A 28-year-old lady is suspected to have polycystic ovarian disease. Samples for testing LH and FSH are best taken on which days of the menstrual cycle?

Day 10. **Explanation:** In the context of Polycystic Ovarian Syndrome (PCOS), the hormonal hallmark is an **elevated LH:FSH ratio** (typically >2:1 or 3:1). While baseline hormonal testing in a normal cycle is usually done on Day 2 or 3, PCOS is characterized by chronic anovulation and a "steady state" of hormonal imbalance. **Why Day 10 is the correct answer:** In a typical 28-day cycle, Day 10 falls in the **late follicular phase**. In patients with PCOS, the characteristic elevation of LH is most pronounced and consistently demonstrable during this period. Testing at this stage highlights the failure of the follicular transition and the persistent high levels of LH that contribute to the-hyperandrogenism and follicular arrest seen in this condition. **Analysis of Incorrect Options:** * **Day 4 (Early Follicular Phase):** While often used for baseline FSH to check ovarian reserve, it may not show the peak diagnostic LH elevation characteristic of PCOS as clearly as the mid-to-late follicular phase. * **Days 13-15 (Periovulatory Phase):** This is the time of the physiological LH surge in normal cycles. Testing here would make it impossible to distinguish between a normal mid-cycle surge and the pathological LH elevation of PCOS. * **Days 24-26 (Luteal Phase):** During this phase, progesterone is dominant. In PCOS, patients are often anovulatory, meaning there is no true luteal phase, making testing during these days unreliable for diagnosis. **High-Yield Clinical Pearls for NEET-PG:** * **LH:FSH Ratio:** A ratio >2:1 is suggestive, though no longer a mandatory Rotterdam criterion for diagnosis. * **Rotterdam Criteria:** Diagnosis requires 2 out of 3: (1) Clinical/biochemical hyperandrogenism, (2) Oligo/anovulation, (3) Polycystic ovaries on USG. * **Gold Standard for PCOS Morphology:** Transvaginal Ultrasound (TVS) showing ≥12 follicles (2-9mm) or ovarian volume >10ml. * **Best Initial Test for Hirsutism in PCOS:** Free testosterone levels.

Q: What is the investigation of choice for hyperprolactinemia?

Prolactin estimation. **Explanation:** **Why Prolactin estimation is the correct answer:** Hyperprolactinemia is defined as a persistent elevation of serum prolactin levels (>25 ng/mL in non-pregnant females). The **investigation of choice** to diagnose this condition is the direct measurement of **Serum Prolactin levels**. Ideally, the sample should be taken in a fasting state, in the morning, and without recent breast stimulation or pelvic examination, as these can cause physiological spikes. If a single value is mildly elevated, the test should be repeated to confirm the diagnosis before initiating imaging or treatment. **Why the other options are incorrect:** * **TRH estimation (A):** While primary hypothyroidism causes an increase in TRH (which stimulates prolactin release), TRH levels are not routinely measured clinically. Instead, TSH is measured to rule out hypothyroidism as a secondary cause. * **LH estimation (B):** LH levels are often suppressed in hyperprolactinemia (leading to anovulation), but they are not diagnostic of the condition itself. * **Estradiol estimation (D):** Hyperprolactinemia leads to a hypoestrogenic state, but measuring estradiol is non-specific and does not identify the underlying cause. **High-Yield Clinical Pearls for NEET-PG:** * **Hook Effect:** In cases of giant prolactinomas with extremely high prolactin, a lab artifact may show falsely low levels. Serial dilution of the serum is required for an accurate reading. * **Gold Standard Imaging:** Once hyperprolactinemia is confirmed biochemically, **Contrast-enhanced MRI of the Sella** is the investigation of choice to rule out a pituitary adenoma. * **Drug of Choice:** **Cabergoline** (a dopamine agonist) is the first-line treatment, preferred over Bromocriptine due to better efficacy and fewer side effects. * **Rule out:** Always exclude pregnancy (hCG test) and hypothyroidism (TSH test) in any patient presenting with elevated prolactin.

Q: What is the commonest cause of female pseudohermaphroditism?

Congenital adrenal hyperplasia. **Explanation:** **Female pseudohermaphroditism** (now referred to as 46,XX Disorder of Sexual Development) is characterized by a normal female genotype (46,XX) and normal ovaries, but with ambiguous or virilized external genitalia due to excess androgen exposure in utero. **Why Congenital Adrenal Hyperplasia (CAH) is correct:** CAH is the **most common cause** of female pseudohermaphroditism, accounting for approximately 90-95% of cases. It is an autosomal recessive disorder, most commonly due to **21-hydroxylase deficiency**. This enzyme defect impairs cortisol synthesis, leading to an increase in Adrenocorticotropic Hormone (ACTH). Elevated ACTH overstimulates the adrenal cortex, diverting precursors into the androgen pathway, resulting in fetal virilization. **Analysis of Incorrect Options:** * **A & C (Virilizing ovarian tumor / Exogenous androgen):** While maternal exposure to androgenic drugs or maternal androgen-secreting tumors (like Luteoma of pregnancy) can cause virilization of a female fetus, these are significantly rarer than CAH. * **B (Ovarian dysgenesis):** This (e.g., Turner Syndrome) typically presents with streak gonads and primary amenorrhea, but the external genitalia are usually normally developed female, not virilized. **NEET-PG High-Yield Pearls:** * **Most common enzyme deficiency in CAH:** 21-hydroxylase (leads to high 17-OH Progesterone). * **Prader Staging:** Used to grade the degree of virilization of external genitalia. * **Clinical Presentation:** Look for salt-wasting (hyponatremia, hyperkalemia) in the classic form. * **Internal Genitalia:** In female pseudohermaphroditism, the **Mullerian structures (uterus, tubes, upper vagina) are always present** because there is no Anti-Mullerian Hormone (AMH).

Question 1

Precocious puberty is most characteristic of which of the following conditions?

Accepted Answer

Albright's syndrome

Answer

Jaffe's Syndrome

Answer

Monostotic fibrous dysplasia

Answer

Osteogenesis imperfecta

Question 2

Which of the following prostaglandins induces aromatase activity in endometrial stromal cells?

Accepted Answer

PGE2

Answer

PGE1

Answer

PGF2

Answer

PGD2

Question 3

A sample of cervical mucus is taken on Day 12 of the menstrual cycle. The mucus is thin, clear, and elastic. When placed under a microscope, what microscopic finding would be expected?

Accepted Answer

A fern pattern characteristic of estrogen

Answer

Clear field devoid of bacteria

Answer

Thick mucus with background bacteria

Answer

Clearly defined, parabasal cells

Question 4

Which of the following clinical features is seen in Polycystic Ovarian Disease (PCOD)?

Accepted Answer

Streak ovaries

Answer

Hirsutism

Answer

Secondary amenorrhea

Answer

Elevated FSH/LH ratio

Question 5

Which of the following is NOT a typical sign of hyperandrogenism seen in Polycystic Ovary Syndrome (PCOS)?

Accepted Answer

Clitoromegaly

Answer

Hirsutism

Answer

Androgenic Alopecia

Answer

Acne

Question 6

A 28-year-old lady is suspected to have polycystic ovarian disease. Samples for testing LH and FSH are best taken on which days of the menstrual cycle?

Accepted Answer

Day 10

Answer

Day 4

Answer

Days 13-15

Answer

Days 24-26

Question 7

What is the investigation of choice for hyperprolactinemia?

Accepted Answer

Prolactin estimation

Answer

TRH estimation

Answer

LH estimation

Answer

Estradiol estimation

Question 8

Which of the following is a definition of delayed puberty in a female?

Accepted Answer

Menarche after 16 years of age

Answer

No breast budding by 13 years of age

Answer

Menarche more than 1 year after the onset of breast budding

Answer

FSH less than 20 mIU/mL in a 16-year-old female

Question 9

What is the commonest cause of female pseudohermaphroditism?

Accepted Answer

Congenital adrenal hyperplasia

Answer

Virilizing ovarian tumor

Answer

Ovarian dysgenesis

Answer

Exogenous androgen

Question 10

What is a primary use of GnRH analogues?

Accepted Answer

Polycystic Ovarian Syndrome (PCOS)

Answer

Galactogenesis

Answer

Contraception

Answer

None of the above

Reproductive Endocrinology — MCQs

Reproductive Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?